Nalfurafine Hydrochloride Shows Promise for Treating Pruritus in Hemodialysis Patients
A multi-center clinical study is evaluating the efficacy and safety of nalfurafine hydrochloride in treating pruritus in hemodialysis patients over 12 weeks.
Asset / Drug
Drug and asset intelligence for Nalfurafine with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.